|
Research Project:
COUNTERMEASURES TO PREVENT AND CONTROL TUBERCULOSIS IN CATTLE AND WILDLIFE RESERVOIRS
Location: Infectious Bacterial Diseases Research Unit
Title: Biomarkers of CD4+ CTL cell Mediated Immunity to Tuberculosis
Authors
 | Endsley, Janice - UNIV. OF TX MED. BR. |  | Hogg, Alison - INST. FOR AN. HEALTH, UK |  | Shell, Lis - UNIV. OF TX MED. BR. |  | Mcalauy, Martin - INST. FOR AN. HEALTH, UK |  | Scherer, Charles - UNIV. OF TX MED. BR. |  | Coffey, Tracey - INST. FOR AN. HEALTH, UK |  | Howard, Chris - INST. FOR AN. HEALTH, UK |  |
Nonnecke, Brian
|  |
Waters, Wade
|  | Estes, D - UNIV. OF TX MED. BR. |
Submitted to: Meeting Abstract
Publication Type: Abstract Only
Publication Acceptance Date: May 18, 2007
Publication Date: May 18, 2007
Citation: Endsley, J.J., Hogg, A., Shell, L., Mcalauy, M., Scherer, C.C., Coffey, T., Howard, C., Nonnecke, B.J., Waters, W.R., Estes, D.M. 2007. Biomarkers of CD4+ CTL cell Mediated Immunity to Tuberculosis [abstract]. American Association of Imunologists. p. 43.49.
Technical Abstract:
The immune responses mediated by interactions between T-lymphocyte subsets and mycobacteria-infected macrophages are critical for control of tuberculosis. In these studies, the bovine model was used to characterize the cytolytic and mycobactericidal CD4+ T cell response induced by BCG vaccination. Antigenic stimulation of CD4+ T-cells from BCG vaccinated cattle induced expression of perforin and IFNgamma in cells expressing a CD45RA-, CD45RO+, and CD62L+ cell surface phenotype. Antigen specific enhancement of granulysin, IFNgamma, perforin, IL-4, IL-13, and IL-21 mRNA expression was detected and not detected for IL-2, IL-6, IL-10, IL-15, TNF {alpha}<https://webmail.utmb.edu/math/agr.gif>, FasL, and CD40L. Following antigenic stimulation, CD4+ T cells from BCG vaccinated animals contributed to reduction of intracellular BCG in infected macrophages. These results demonstrate that vaccination with BCG induces a subpopulation of mycobacteria-specific CD4+ T cells that are characterized by the expression of a cell-surface memory phenotype, enhanced expression of mycobactericidal molecules, and anti-mycobacterial activity against intracellular M. bovis.
This work was supported by the NIAID Fellowship for Training in Emerging and Re-emerging Infectious Disease and the Sealy Center for Vaccine Development, UTMB, the Texas-United Kingdom Collaborative Research Initiative, and the Institute for Animal Health by DEFRA and the BBSRC, UK.
|
|
|
|
|